As of 2025-05-03, the Intrinsic Value of Tmc Life Sciences Berhad (TMCLIFE.KL) is 0.24 MYR. This TMCLIFE.KL valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 0.48 MYR, the upside of Tmc Life Sciences Berhad is -50.20%.
The range of the Intrinsic Value is 0.12 - 1.04 MYR
Based on its market price of 0.48 MYR and our intrinsic valuation, Tmc Life Sciences Berhad (TMCLIFE.KL) is overvalued by 50.20%.
Range | Selected | Upside | |
a | |||
DCF (Growth 5y) | 0.12 - 1.04 | 0.24 | -50.2% |
DCF (Growth 10y) | 0.43 - 3.32 | 0.78 | 64.5% |
DCF (EBITDA 5y) | 0.52 - 0.78 | 0.65 | 36.6% |
DCF (EBITDA 10y) | 0.76 - 1.28 | 1.00 | 110.0% |
Fair Value | 0.18 - 0.18 | 0.18 | -62.75% |
P/E | 0.14 - 0.41 | 0.25 | -47.5% |
EV/EBITDA | 0.17 - 0.54 | 0.36 | -23.4% |
EPV | 0.17 - 0.28 | 0.22 | -53.4% |
DDM - Stable | 0.07 - 0.41 | 0.24 | -49.7% |
DDM - Multi | 0.53 - 1.87 | 0.77 | 62.8% |
Market Cap (mil) | 827.39 |
Beta | 0.60 |
Outstanding shares (mil) | 1,741.88 |
Enterprise Value (mil) | 856.72 |
Market risk premium | 6.85% |
Cost of Equity | 8.63% |
Cost of Debt | 5.81% |
WACC | 7.72% |